drugset / Trial / NCT02571257

Efficacy and Safety of Gemcabene in Hypercholesterolemic Patients on Stable Statin Therapy

NCT02571257

Phase 2 Completed 66 enrolled NeuroBo Pharmaceuticals Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the effect of gemcabene on LDL-C and other lipid parameters in hypercholesterolemic patients on a stable dose of a statin.

Timeline

Start
2000-08
Primary completion
2002-04
Completion
2002-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Gemcabene Small molecule 300 mg
Subject Gemcabene Small molecule 900 mg

Indications